A detailed history of Squarepoint Ops LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 38,967 shares of HLVX stock, worth $72,868. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,967
Holding current value
$72,868
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.58 - $14.42 $61,567 - $561,904
38,967 New
38,967 $68,000
Q2 2022

Aug 15, 2022

BUY
$8.7 - $20.18 $159,801 - $370,666
18,368 New
18,368 $201,000

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $62.5M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.